NCT03099356 2025-08-01
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
University of Michigan Rogel Cancer Center
Phase 2 Recruiting
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
Hannover Medical School